Uses
6-Bromo-1-methyl-1H-indazole serves as a coupling partner in palladium/XPhos-catalyzed reactions, reacting with benzyl bromide to give 6-benzyl-1-methyl-1H-indazole and with bromomethyl phenyl sulfone to give 1-methyl-6-[(phenylsulfonyl)methyl]-1H-indazole[3]. With 6,7-dimethoxy-1-methylisoquinoline N-oxide, NaOtBu, Pd2dba3 and XPhos in toluene, it is converted to 6,7-dimethoxy-1-((1-methyl-1H-indazol-6-yl)methyl)isoquinoline, isolated as the HCl salt[4].
Synthesis
6-Bromo-1H-indazole (400 mg) was dissolved in methanol (10 mL). Potassium hydroxide (450 mg) and iodomethane (0.50 mL) were added sequentially to this solution and the reaction mixture was heated to reflux for 2.5 hours. After completion of the reaction, it was cooled to room temperature, diluted with ether, washed sequentially with water and saturated saline, and the organic phase was dried over anhydrous sodium sulfate and concentrated. The target product 6-bromo-1-methylindazole (160 mg) and its isomers were isolated by Combiflash fast column chromatography.
References
[1] Patent: EP1622569, 2015, B1. Location in patent: Paragraph 0411
[2] European Journal of Medicinal Chemistry, 2019, vol. 161, p. 533 - 542
[3]
Abdiaj, I., Cañellas, S., Dieguez, A., Linares, M. L., Pijper, B., Fontana, A., Rodriguez, R., Trabanco, A., Palao, E., Alcázar, J. (2022). End-to-End Automated Synthesis of C(sp
3)-Enriched Drug-like Molecules
via Negishi Coupling and Novel, Automated Liquid–Liquid Extraction. Journal of Medicinal Chemistry, 66(1), 716–732.
https://doi.org/10.1021/acs.jmedchem.2c01646 [4]
Haines, B. J., Kreamer, M., Benej, M., Mohammed, S., Bridge, H., Bayrali-Ulker, E., Fergatova, A., Williams, T. M., Li, Z., Papandreou, I., Denko, N. C., Mitton-Fry, M. J. (2025). Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer. Journal of Medicinal Chemistry, 68(21), 23140–23162.
https://doi.org/10.1021/acs.jmedchem.5c02014